BIONDVAX
BiondVax Pharmaceuticals, a publicly-traded company (TASE: BNDX) located in the Weizmann Science Park in Ness-Ziona (Israel), is dedicated to the development of a novel Universal Influenza Vaccine. BiondVax's Universal Flu Vaccine is based on research carried out over a period of 20 years by Weizmann Institute Professor Ruth Arnon, who heads the company's Scientific Advisory Board. Professor Arnon is well-known for her part in the development of Copaxone®, a blockbuster drug for the treatment o... f multiple sclerosis. The Company holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, for developing, manufacturing and commercializing this innovative flu vaccine. BiondVax’s team of 14 includes scientists, technicians, researchers, and administrative staff. The company’s state-of-the-art GMP facility in Ness-Ziona houses its laboratories, production facilities and offices.
BIONDVAX
Industry:
Biotechnology Health Care Information Technology
Founded:
2003-01-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.biondvax.com
Total Employee:
11+
Status:
Active
Contact:
(972) 893-0252
Total Funding:
45.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Organization Schema Office 365 Mail
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Biocytogen
Biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Peptidream
Peptidream is a biopharmaceutical company.
Sinovant Sciences
Sinovant Sciences is an innovative biopharmaceutical company.
YS Biopharma
YS Biopharma is a global, fully integrated bio-pharmaceutical company.
Current Employees Featured
Tamar Ben-Yedidia Chief Scientific Officer @ BiondVax
Chief Scientific Officer
2005-03-01
Shimon Hassin Chief Administrative Officer @ BiondVax
Chief Administrative Officer
Elad Mark Chief Operating Officer @ BiondVax
Chief Operating Officer
2018-09-01
Moran Ahdout Fruchter Chief Of Staff @ BiondVax
Chief Of Staff
2021-09-01
Uri Ben CFO @ BiondVax
CFO
Amir Reichman Chief Executive Officer @ BiondVax
Chief Executive Officer
2021-02-01
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - BiondVax
Office of the Chief Scientist
Office of the Chief Scientist investment in Grant - BiondVax
Official Site Inspections
http://www.biondvax.com Semrush global rank: 7.47 M Semrush visits lastest month: 481
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "BiondVax"
FAQs 1 - BiondVax Pharmaceuticals Ltd
BiondVax FAQ. When was BiondVax founded, and what has the company achieved? BiondVax was founded in 2003 by Dr. Ron Babecoff, based on …See details»
About BiondVax — BiondVax Pharmaceuticals Ltd
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is a biopharmaceutical company focused on developing, manufacturing, and commercializing …See details»
BiondVax Pharmaceuticals Ltd
Our Mission: To help build a healthier and happier world by developing, manufacturing and ultimately commercializing products for the prevention and treatment of infectious diseases and other illnesses.See details»
BiondVax Pharmaceuticals Ltd. | LinkedIn
BiondVax Pharmaceuticals Ltd. | 2,759 followers on LinkedIn. Nasdaq: BVXV | BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is a biopharmaceutical company focused on …See details»
BiondVax Signs Deals For Development And Commercialization Of …
Dec 22, 2021 (RTTNews) - BiondVax Pharmaceuticals Ltd. (BVXV) said that it has signed definitive agreements with the Max Planck Society, the parent organization of the Max Planck …See details»
BIONDVAX PHARMACEUTICALS LTD Company Profile - Dun
See other industries within the Manufacturing sector: Aerospace Product and Parts Manufacturing , Agriculture, Construction, and Mining Machinery Manufacturing , Alumina and Aluminum …See details»
BiondVax Pharmaceuticals Ltd - BIO CEO & Investor Conference
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. BiondVax Pharmaceuticals Ltd - …See details»
Management - BiondVax Pharmaceuticals Ltd
Joshua E Phillipson | Director of Communications & Investor Relations. Copyright 2023 BiondVax Pharmaceuticals Ltd. All Rights Reserved | Terms & Conditions | Privacy ...See details»
Biotech Executive Joins BiondVax's Board of Directors
Jun 28, 2018 BiondVax Pharmaceuticals announced the appointment of Mark Germain as Vice-Chairman of its Board of Directors. Based in New York, and having served as founder, …See details»
BiondVax Announces Appointment of Amir Reichman …
Jan 21, 2021 BiondVax Announces Appointment of Amir Reichman as New CEO Pharma Industry Veteran in Vaccines will Assume Role Full Time March 2, 2021, with Focus on Developing Product Pipeline in Infectious ...See details»
BiondVax Announces Appointment of Amir Reichman …
Jan 21, 2021 Mr. Reichman and Ron Babecoff, BiondVax's founder and current CEO, will share duties during a transition period while Mr. Reichman completes his work obligations at GlaxoSmithKline, a global ...See details»
Board of Directors - BiondVax Pharmaceuticals Ltd
Dr. Yael Margolin has more than 35 years of experience as senior manager, CEO and board member in venture capital and in the pharmaceutical and biotech industries, leading strategic …See details»
BiondVax grows vaccine production with new facility
Jul 19, 2017 Dive Insight: BiondVax is financing the new facility with a grant from Israel's Ministry of Economy and Industry worth a little more than $1 million, as well as a €20 million (about $22 …See details»
BiondVax signs definitive agreements for development and ...
Dec 22, 2021 The collaboration has been facilitated by kENUP, a civic society organization promoting innovative industries in Europe. About BiondVax: BiondVax Pharmaceuticals Ltd. …See details»
Letter from BiondVax's New CEO to Shareholders - Nasdaq
Mar 23, 2021 After many years of pharmaceutical leadership positions in the US and Europe, I jumped at the opportunity to return to my roots in Israel to take over the reins as BiondVax's …See details»
BiondVax - Company Profile - Tracxn
3 days ago BiondVax - Developer of a vaccine against influenza virus. Public Company. Raised funding over 4 rounds from 3 investors. BiondVax has 759 competitors.See details»
Company Presentation — BiondVax Pharmaceuticals Ltd
Skip to Content Home AboutSee details»
BiondVax signs definitive agreements for development and ...
JERUSALEM, Dec. 22, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing …See details»
BIONOVA X - DLP 3D Bioprinter - CELLINK
With the BIONOVA X, we are meeting the demand for more precise, biomimetic models for high throughput applications. We’re enabling the effortless recapitulation of microarchitectures, …See details»
BiondVax signs definitive agreements for development and ...
Dec 22, 2021 Jerusalem, Israel – December 22, 2021 – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and …See details»